<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00389883</url>
  </required_header>
  <id_info>
    <org_study_id>P050320</org_study_id>
    <nct_id>NCT00389883</nct_id>
  </id_info>
  <brief_title>Anaesthesia for Supratentorial Tumor Resection</brief_title>
  <official_title>Anaesthesia for Supratentorial Tumor Resection : a Double-blind Comparison of Target Plasma Concentration of Propofol-remifentanil and Sevoflurane-sufentanil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double center, multidisciplinary, prospective, randomized, double-blind, with a
      superiority hypothesis, trial including 100 patients scheduled for resection of a
      supratentorial brain tumour under general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On the morning of surgery, patients will be randomly allocated to one of the two following
      groups : target concentration-delivered propofol-remifentanil versus sufentanil-sevoflurane.
      The primary judgement criterion will be the rapidity of awakening, defined as the time
      between the cessation of administration of the last anesthetic until extubation. Several
      secondary judgement criteria related to quality of postoperative recovery and complications
      will be collected. The hypothesis tested is a 30% reduction of the time necessary to extubate
      patients after cessation of anesthetic delivery in the propofol-remifentanil group. Based on
      previous works, using an risk of 20 % and an of 5 %, 100 patients must be included in this
      study (50 or each group). Statistical analysis will be performed by WILCOXON MANN, WHITNEY
      and X2 tests based on the type of variables.

      The results of this study should provide a first choice anaesthetic regimen to optimize
      postoperative recovery of neurosurgical patients undergoing resection of supratentorial brain
      tumours. They will contribute to the improvement in the management of patients suffering from
      cancer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from discontinuing anesthesia and extubation.</measure>
    <time_frame>during 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Speed of emergence from anesthesia : time from discontinuing anesthesia to spontaneous breathing, opening the eyes, response to simple order and discharge from postoperative care unit.</measure>
    <time_frame>during 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of emergence from anesthesia : agitation, postoperative pain, nausea and vomiting, cognitive functions.</measure>
    <time_frame>during 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of surgical procedure : Coma glasgow scale, surgical procedure difficulties.</measure>
    <time_frame>during 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Supratentorial Neoplasms</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol et remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sevoflurane et sufentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Comparison of two anesthetics protocol</intervention_name>
    <description>Comparison of two anesthetics protocol</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient scheduled for supratentorial brain tumors remove.

          -  Age : 18 to 75.

          -  ASA 1 or 2.

        Exclusion Criteria:

          -  Disagree of patient to participate

          -  Intubation required in the postoperative care unit

          -  Contraindication of one of the anesthetics used in the study

          -  Pregnancy

          -  Craniotomy in the frontal area (no depth of anesthesia monitoring)

          -  Patient's inability to quantified its pain.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Souhayl DAHMANI, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire.</name>
      <address>
        <city>Besancon</city>
        <zip>25030 CEDEX</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital BEAUJON ASSISTANCE PUBLIQUE</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Todd MM, Warner DS, Sokoll MD, Maktabi MA, Hindman BJ, Scamman FL, Kirschner J. A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/nitrous oxide. Anesthesiology. 1993 Jun;78(6):1005-20.</citation>
    <PMID>8512094</PMID>
  </results_reference>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2006</study_first_submitted>
  <study_first_submitted_qc>October 18, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2006</study_first_posted>
  <last_update_submitted>July 6, 2012</last_update_submitted>
  <last_update_submitted_qc>July 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>supratentorial brain tumors</keyword>
  <keyword>propofol</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>remifentanil</keyword>
  <keyword>sufentanil.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Supratentorial Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

